| pubmed-article:4420821 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:4420821 | lifeskim:mentions | umls-concept:C0006675 | lld:lifeskim |
| pubmed-article:4420821 | lifeskim:mentions | umls-concept:C0026549 | lld:lifeskim |
| pubmed-article:4420821 | lifeskim:mentions | umls-concept:C0006104 | lld:lifeskim |
| pubmed-article:4420821 | lifeskim:mentions | umls-concept:C0205147 | lld:lifeskim |
| pubmed-article:4420821 | lifeskim:mentions | umls-concept:C0001962 | lld:lifeskim |
| pubmed-article:4420821 | lifeskim:mentions | umls-concept:C0333668 | lld:lifeskim |
| pubmed-article:4420821 | pubmed:issue | 4158 | lld:pubmed |
| pubmed-article:4420821 | pubmed:dateCreated | 1974-12-28 | lld:pubmed |
| pubmed-article:4420821 | pubmed:abstractText | Administration of morphine or ethanol to rats produces a decrease in regional brain calcium in vivo. This effect is selectively antagonized by the stereospecific narcotic antagonist naloxone. Reserpine and the dopamine-acetaldehyde conjugate salsolinol also produce a depletion of regional brain calcium, but only the salsolinol depletion is antagonized by naloxone. Experiments with naloxone provide evidence for two calcium-sensitive pools in the central nervous system. | lld:pubmed |
| pubmed-article:4420821 | pubmed:language | eng | lld:pubmed |
| pubmed-article:4420821 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4420821 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:4420821 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4420821 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4420821 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4420821 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4420821 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4420821 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4420821 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:4420821 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:4420821 | pubmed:issn | 0036-8075 | lld:pubmed |
| pubmed-article:4420821 | pubmed:author | pubmed-author:MedinaM AMA | lld:pubmed |
| pubmed-article:4420821 | pubmed:author | pubmed-author:RossD HDH | lld:pubmed |
| pubmed-article:4420821 | pubmed:author | pubmed-author:CardenasH LHL | lld:pubmed |
| pubmed-article:4420821 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:4420821 | pubmed:day | 4 | lld:pubmed |
| pubmed-article:4420821 | pubmed:volume | 186 | lld:pubmed |
| pubmed-article:4420821 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:4420821 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:4420821 | pubmed:pagination | 63-5 | lld:pubmed |
| pubmed-article:4420821 | pubmed:dateRevised | 2009-10-27 | lld:pubmed |
| pubmed-article:4420821 | pubmed:meshHeading | pubmed-meshheading:4420821-... | lld:pubmed |
| pubmed-article:4420821 | pubmed:meshHeading | pubmed-meshheading:4420821-... | lld:pubmed |
| pubmed-article:4420821 | pubmed:meshHeading | pubmed-meshheading:4420821-... | lld:pubmed |
| pubmed-article:4420821 | pubmed:meshHeading | pubmed-meshheading:4420821-... | lld:pubmed |
| pubmed-article:4420821 | pubmed:meshHeading | pubmed-meshheading:4420821-... | lld:pubmed |
| pubmed-article:4420821 | pubmed:meshHeading | pubmed-meshheading:4420821-... | lld:pubmed |
| pubmed-article:4420821 | pubmed:meshHeading | pubmed-meshheading:4420821-... | lld:pubmed |
| pubmed-article:4420821 | pubmed:meshHeading | pubmed-meshheading:4420821-... | lld:pubmed |
| pubmed-article:4420821 | pubmed:meshHeading | pubmed-meshheading:4420821-... | lld:pubmed |
| pubmed-article:4420821 | pubmed:meshHeading | pubmed-meshheading:4420821-... | lld:pubmed |
| pubmed-article:4420821 | pubmed:meshHeading | pubmed-meshheading:4420821-... | lld:pubmed |
| pubmed-article:4420821 | pubmed:meshHeading | pubmed-meshheading:4420821-... | lld:pubmed |
| pubmed-article:4420821 | pubmed:meshHeading | pubmed-meshheading:4420821-... | lld:pubmed |
| pubmed-article:4420821 | pubmed:meshHeading | pubmed-meshheading:4420821-... | lld:pubmed |
| pubmed-article:4420821 | pubmed:meshHeading | pubmed-meshheading:4420821-... | lld:pubmed |
| pubmed-article:4420821 | pubmed:meshHeading | pubmed-meshheading:4420821-... | lld:pubmed |
| pubmed-article:4420821 | pubmed:meshHeading | pubmed-meshheading:4420821-... | lld:pubmed |
| pubmed-article:4420821 | pubmed:meshHeading | pubmed-meshheading:4420821-... | lld:pubmed |
| pubmed-article:4420821 | pubmed:meshHeading | pubmed-meshheading:4420821-... | lld:pubmed |
| pubmed-article:4420821 | pubmed:year | 1974 | lld:pubmed |
| pubmed-article:4420821 | pubmed:articleTitle | Morphine and ethanol: selective depletion of regional brain calcium. | lld:pubmed |
| pubmed-article:4420821 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:4420821 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:4420821 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:4420821 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:4420821 | lld:pubmed |
